These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 2542913)
1. Use of progestins. Mishell DR Postgrad Med; 1989 Apr; Spec No():84-8; discussion 89-90. PubMed ID: 2542913 [TBL] [Abstract][Full Text] [Related]
2. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy. Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201 [TBL] [Abstract][Full Text] [Related]
3. Effects of continuous combined conjugated estrogen/medroxyprogesterone acetate and 17beta-estadiol/norethisterone acetate on lipids and lipoproteins. Odmark IS; Bäckström T; Haeger M; Jonsson B; Bixo M Maturitas; 2004 Jun; 48(2):137-46. PubMed ID: 15172088 [TBL] [Abstract][Full Text] [Related]
4. Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium. Whitehead MI; Townsend PT; Pryse-Davies J; Ryder TA; King RJ N Engl J Med; 1981 Dec; 305(27):1599-605. PubMed ID: 7312007 [TBL] [Abstract][Full Text] [Related]
5. [Postmenopausal estrogen therapy: pharmacological treatment or replacement of the lacking hormone?]. Lippert TH; Seeger H; Mueck AO Dtsch Med Wochenschr; 1999 Oct; 124(42):1245-8. PubMed ID: 10572534 [No Abstract] [Full Text] [Related]
7. HRT dosing regimens: continuous versus cyclic-pros and cons. Shoupe D Int J Fertil Womens Med; 2001; 46(1):7-15. PubMed ID: 11294619 [TBL] [Abstract][Full Text] [Related]
8. Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy. Ylikorkala O; Lim P; Caubel P Clin Ther; 2000 May; 22(5):622-36. PubMed ID: 10868559 [TBL] [Abstract][Full Text] [Related]
9. Bleeding patterns in postmenopausal women using continuous combination hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate or with 17beta-estradiol and norethindrone acetate. Odmark IS; Jonsson B; Bäckström T Am J Obstet Gynecol; 2001 May; 184(6):1131-8. PubMed ID: 11349178 [TBL] [Abstract][Full Text] [Related]
10. A comparison of the central effects of different progestins used in hormone replacement therapy. Cagnacci A; Arangino S; Baldassari F; Alessandrini C; Landi S; Volpe A Maturitas; 2004 Aug; 48(4):456-62. PubMed ID: 15283939 [TBL] [Abstract][Full Text] [Related]
11. Comparison of lipid and androgen levels after conjugated estrogen or depo-medroxyprogesterone acetate treatment in postmenopausal women. Barnes RB; Roy S; Lobo RA Obstet Gynecol; 1985 Aug; 66(2):216-9. PubMed ID: 2991832 [TBL] [Abstract][Full Text] [Related]
12. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women. Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449 [TBL] [Abstract][Full Text] [Related]
13. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women. Keramaris NC; Christodoulakos GE; Lambrinoudaki IV; Dalamanga A; Alexandrou AP; Bramis J; Bastounis E; Creatsas GC Climacteric; 2007 Oct; 10(5):400-7. PubMed ID: 17852143 [TBL] [Abstract][Full Text] [Related]
14. Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations. Whitcroft SI; Crook D; Marsh MS; Ellerington MC; Whitehead MI; Stevenson JC Obstet Gynecol; 1994 Aug; 84(2):222-6. PubMed ID: 8041534 [TBL] [Abstract][Full Text] [Related]
15. Progestins abrogate estrogen-induced changes in the insulin-like growth factor axis. Heald A; Selby PL; White A; Gibson JM Am J Obstet Gynecol; 2000 Sep; 183(3):593-600. PubMed ID: 10992179 [TBL] [Abstract][Full Text] [Related]
16. Pseudopregnancy induced by estrogen-progestogen or progestogens alone in the treatment of endometriosis. Moghissi KS Prog Clin Biol Res; 1990; 323():221-32. PubMed ID: 2137617 [No Abstract] [Full Text] [Related]
17. Clinical and metabolic responses of menopausal women to sequential versus continuous estrogen and progestin replacement therapy. Luciano AA; Turksoy RN; Carleo J; Hendrix JW Obstet Gynecol; 1988 Jan; 71(1):39-43. PubMed ID: 2827082 [TBL] [Abstract][Full Text] [Related]
18. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels. Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353 [TBL] [Abstract][Full Text] [Related]
19. Effects of four different regimens of hormone replacement therapy on hemostatic parameters: a prospective randomized study. Taner MZ; Ozpolat E; Taskiran C; Onan MA; Gursel T; Karabulut E; Gursoy R; Himmetoglu O Maturitas; 2006 Feb; 53(3):267-73. PubMed ID: 15978753 [TBL] [Abstract][Full Text] [Related]
20. [Hormonal treatment of the menopause and vascular pathology]. Rozenbaum H J Mal Vasc; 1984; 9 Suppl A():32-4. PubMed ID: 6330256 [No Abstract] [Full Text] [Related] [Next] [New Search]